Therefore, lncRNA HAND2-AS1 may be used to assist early diagnosis of NSCLC and lncRNA HAND2-AS1 overexpression may serve as a promising target for NSCLC treatment. This evidence concerns the gene HAND2 and non-small cell lung carcinoma.